EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H19Cl2N7O |
| Net Charge | 0 |
| Average Mass | 408.293 |
| Monoisotopic Mass | 407.10281 |
| SMILES | Cc1nn(C)c2nc(NNC(=O)Nc3cc(Cl)nc(Cl)c3)cc(C(C)C)c12 |
| InChI | InChI=1S/C17H19Cl2N7O/c1-8(2)11-7-14(22-16-15(11)9(3)25-26(16)4)23-24-17(27)20-10-5-12(18)21-13(19)6-10/h5-8H,1-4H3,(H,22,23)(H2,20,21,24,27) |
| InChIKey | RNSLRQNDXRSASX-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Roles: | sphingosine-1-phosphate receptor 2 antagonist Any sphingosine-1-phosphate receptor (S1PR) antagonist that acts as an antagonist for the subtype 2 receptors (S1PR2). osteogenesis regulator Any compound that induces or regulates osteogenesis. |
| Applications: | anti-asthmatic agent Any compound that has anti-asthmatic effects. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. anti-inflammatory agent Any compound that has anti-inflammatory effects. pro-angiogenic agent Any compound that promotes the growth of new blood vessels from pre-existing vessels. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| JTE-013 (CHEBI:195541) has functional parent semicarbazide (CHEBI:28306) |
| JTE-013 (CHEBI:195541) has role anti-asthmatic agent (CHEBI:65023) |
| JTE-013 (CHEBI:195541) has role anti-inflammatory agent (CHEBI:67079) |
| JTE-013 (CHEBI:195541) has role antineoplastic agent (CHEBI:35610) |
| JTE-013 (CHEBI:195541) has role osteogenesis regulator (CHEBI:63054) |
| JTE-013 (CHEBI:195541) has role pro-angiogenic agent (CHEBI:72571) |
| JTE-013 (CHEBI:195541) has role sphingosine-1-phosphate receptor 2 antagonist (CHEBI:195542) |
| JTE-013 (CHEBI:195541) is a chloropyridine (CHEBI:39173) |
| JTE-013 (CHEBI:195541) is a pyrazolopyridine (CHEBI:46699) |
| IUPAC Name |
|---|
| N-(2,6-dichloropyridin-4-yl)-2-[1,3-dimethyl-4-(propan-2-yl)-1H-pyrazolo[3,4-b]pyridin-6-yl]hydrazinecarboxamide |
| Synonyms | Source |
|---|---|
| 1-[1,3-dimethyl-4-(2-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-4-(2,6-dichloro-4-pyridinyl)-semicarbazide | ChEBI |
| JTE 013 | SUBMITTER |
| N-(2,6-dichloropyridin-4-yl)-2-[1,3-dimethyl-4-(propan-2-yl)-1H-pyrazolo[3,4-b]pyridin-6-yl]hydrazine-1-carboxamide | IUPAC |
| 1-(2,6-dichloro-4-pyridinyl)-3-[(1,3-dimethyl-4-propan-2-yl-6-pyrazolo[3,4-b]pyridinyl)amino]urea | ChEBI |
| JTE013 | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| LSM-2961 | LINCS |
| Registry Numbers | Sources |
|---|---|
| CAS:383150-41-2 | ChEBI |
| Citations |
|---|